Shattuck Labs IncNASDAQ:STTK
- LAST PRICE4.1650
- TODAY'S CHANGE (%)0.0000 (0.0000%)
- Bid / Lots4.1700/ 2
- Ask / Lots6.6500/ 1
- Open / Previous Close4.5200 / 4.1650
- Day Range
- 52 Week Range
- Volume460,828
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | STTK |
|---|---|---|
| 09:32 ET | 9547 | 4.5 |
| 09:34 ET | 295 | 4.45 |
| 09:36 ET | 300 | 4.45 |
| 09:38 ET | 4147 | 4.36 |
| 09:39 ET | 100 | 4.435 |
| 09:41 ET | 4514 | 4.5 |
| 09:48 ET | 3331 | 4.48 |
| 09:50 ET | 1100 | 4.51 |
| 09:54 ET | 5399 | 4.55 |
| 09:56 ET | 263 | 4.55 |
| 09:57 ET | 289 | 4.545 |
| 09:59 ET | 726 | 4.495 |
| 10:01 ET | 2414 | 4.47 |
| 10:03 ET | 300 | 4.475 |
| 10:06 ET | 100 | 4.47 |
| 10:08 ET | 2577 | 4.44 |
| 10:10 ET | 3367 | 4.4 |
| 10:12 ET | 100 | 4.36 |
| 10:14 ET | 4121 | 4.34 |
| 10:15 ET | 6287 | 4.28 |
| 10:17 ET | 11180 | 4.28 |
| 10:19 ET | 2675 | 4.28 |
| 10:21 ET | 10069 | 4.29 |
| 10:24 ET | 850 | 4.2801 |
| 10:28 ET | 400 | 4.275 |
| 10:30 ET | 1500 | 4.32 |
| 10:32 ET | 361 | 4.34 |
| 10:33 ET | 1130 | 4.35 |
| 10:35 ET | 500 | 4.38 |
| 10:37 ET | 5012 | 4.41 |
| 10:39 ET | 4165 | 4.42 |
| 10:44 ET | 438 | 4.41 |
| 10:46 ET | 500 | 4.395 |
| 10:48 ET | 429 | 4.4 |
| 10:50 ET | 825 | 4.385 |
| 10:53 ET | 200 | 4.38 |
| 10:55 ET | 100 | 4.37 |
| 10:57 ET | 1591 | 4.39 |
| 11:00 ET | 7660 | 4.38 |
| 11:02 ET | 395 | 4.37 |
| 11:06 ET | 200 | 4.37 |
| 11:08 ET | 200 | 4.37 |
| 11:09 ET | 1817 | 4.385 |
| 11:11 ET | 664 | 4.37 |
| 11:15 ET | 100 | 4.35 |
| 11:18 ET | 942 | 4.35 |
| 11:20 ET | 400 | 4.35 |
| 11:22 ET | 521 | 4.35 |
| 11:24 ET | 100 | 4.35 |
| 11:26 ET | 5841 | 4.36 |
| 11:27 ET | 600 | 4.35 |
| 11:29 ET | 100 | 4.33 |
| 11:31 ET | 620 | 4.3 |
| 11:33 ET | 100 | 4.32 |
| 11:36 ET | 300 | 4.29 |
| 11:38 ET | 300 | 4.285 |
| 11:40 ET | 9196 | 4.33 |
| 11:44 ET | 428 | 4.33 |
| 11:45 ET | 1700 | 4.34 |
| 11:47 ET | 1100 | 4.37 |
| 11:49 ET | 1047 | 4.3525 |
| 11:51 ET | 100 | 4.34 |
| 11:54 ET | 200 | 4.33 |
| 11:58 ET | 1000 | 4.33 |
| 12:00 ET | 100 | 4.315 |
| 12:02 ET | 899 | 4.32 |
| 12:03 ET | 200 | 4.31 |
| 12:05 ET | 700 | 4.305 |
| 12:09 ET | 602 | 4.3 |
| 12:14 ET | 200 | 4.29 |
| 12:16 ET | 100 | 4.3 |
| 12:18 ET | 524 | 4.299 |
| 12:21 ET | 379 | 4.29 |
| 12:25 ET | 134 | 4.275 |
| 12:27 ET | 200 | 4.26 |
| 12:30 ET | 100 | 4.26 |
| 12:32 ET | 6733 | 4.26 |
| 12:34 ET | 1865 | 4.25 |
| 12:36 ET | 5100 | 4.25 |
| 12:38 ET | 10684 | 4.27 |
| 12:41 ET | 2700 | 4.3 |
| 12:43 ET | 2870 | 4.285 |
| 12:45 ET | 100 | 4.3 |
| 12:48 ET | 600 | 4.29 |
| 12:52 ET | 302 | 4.28 |
| 12:56 ET | 400 | 4.28 |
| 12:59 ET | 323 | 4.28 |
| 01:01 ET | 300 | 4.265 |
| 01:03 ET | 687 | 4.255 |
| 01:06 ET | 200 | 4.25 |
| 01:08 ET | 302 | 4.26 |
| 01:10 ET | 1012 | 4.22 |
| 01:12 ET | 4706 | 4.23 |
| 01:14 ET | 400 | 4.24 |
| 01:15 ET | 2594 | 4.2307 |
| 01:19 ET | 1098 | 4.24 |
| 01:21 ET | 1295 | 4.215 |
| 01:24 ET | 504 | 4.21 |
| 01:26 ET | 1100 | 4.21 |
| 01:28 ET | 8128 | 4.24 |
| 01:30 ET | 320 | 4.22 |
| 01:33 ET | 350 | 4.22 |
| 01:35 ET | 100 | 4.23 |
| 01:39 ET | 1397 | 4.21 |
| 01:42 ET | 123 | 4.2 |
| 01:44 ET | 100 | 4.21 |
| 01:46 ET | 2466 | 4.23 |
| 01:50 ET | 326 | 4.22 |
| 01:51 ET | 2348 | 4.2 |
| 01:53 ET | 100 | 4.19 |
| 01:55 ET | 144 | 4.205 |
| 01:57 ET | 100 | 4.205 |
| 02:04 ET | 775 | 4.18 |
| 02:06 ET | 595 | 4.18 |
| 02:08 ET | 1698 | 4.16 |
| 02:09 ET | 500 | 4.15 |
| 02:11 ET | 4287 | 4.185 |
| 02:13 ET | 900 | 4.2 |
| 02:15 ET | 4328 | 4.22 |
| 02:18 ET | 1474 | 4.24 |
| 02:20 ET | 2433 | 4.285 |
| 02:22 ET | 1178 | 4.3 |
| 02:24 ET | 1083 | 4.31 |
| 02:26 ET | 1507 | 4.28 |
| 02:27 ET | 400 | 4.27 |
| 02:31 ET | 1331 | 4.26 |
| 02:33 ET | 2638 | 4.245 |
| 02:36 ET | 327 | 4.24 |
| 02:38 ET | 100 | 4.23 |
| 02:40 ET | 1639 | 4.24 |
| 02:42 ET | 240 | 4.23 |
| 02:44 ET | 711 | 4.24 |
| 02:45 ET | 973 | 4.22 |
| 02:47 ET | 1117 | 4.21 |
| 02:51 ET | 664 | 4.18 |
| 02:54 ET | 926 | 4.17 |
| 02:56 ET | 100 | 4.18 |
| 02:58 ET | 8561 | 4.21 |
| 03:00 ET | 400 | 4.185 |
| 03:02 ET | 4494 | 4.225 |
| 03:03 ET | 100 | 4.22 |
| 03:05 ET | 100 | 4.22 |
| 03:07 ET | 436 | 4.205 |
| 03:09 ET | 25471 | 4.17 |
| 03:12 ET | 2186 | 4.17 |
| 03:14 ET | 100 | 4.16 |
| 03:16 ET | 4978 | 4.15 |
| 03:18 ET | 1064 | 4.15 |
| 03:20 ET | 1450 | 4.14 |
| 03:21 ET | 1548 | 4.14 |
| 03:23 ET | 488 | 4.13 |
| 03:27 ET | 7490 | 4.1799 |
| 03:30 ET | 2628 | 4.17 |
| 03:32 ET | 1400 | 4.16 |
| 03:34 ET | 4634 | 4.145 |
| 03:36 ET | 200 | 4.145 |
| 03:38 ET | 800 | 4.145 |
| 03:39 ET | 3760 | 4.16 |
| 03:41 ET | 712 | 4.165 |
| 03:43 ET | 431 | 4.165 |
| 03:45 ET | 2863 | 4.19 |
| 03:48 ET | 700 | 4.19 |
| 03:50 ET | 1615 | 4.175 |
| 03:52 ET | 1505 | 4.175 |
| 03:54 ET | 3368 | 4.17 |
| 03:56 ET | 4359 | 4.2 |
| 03:57 ET | 13844 | 4.19 |
| 03:59 ET | 4162 | 4.165 |
Yesterday
DJ Shattuck Labs Is Maintained at Buy by HC Wainwright & Co., from 19 hours ago by Dow Jones
19 hours ago by Dow Jones
Jun 17, 2024
DJ Shattuck Labs Is Maintained at Buy by Citigroup, from 11:04AM ET on Monday Jun 17, 2024 by Dow Jones
11:04AM ET on Monday Jun 17, 2024 by Dow Jones
Jun 14, 2024
DJ Shattuck Labs Is Maintained at Buy by Needham, from 12:01PM ET on Friday Jun 14, 2024 by Dow Jones
12:01PM ET on Friday Jun 14, 2024 by Dow JonesShattuck Labs Announces Updated Positive Interim Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 in Combination with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients, from 6:00AM ET on Friday Jun 14, 2024 by Dow Jones
6:00AM ET on Friday Jun 14, 2024 by Dow Jones
Jun 10, 2024
DJ Shattuck Labs Gets FDA's Orphan Drug Status for Leukemia Treatment, from 8:04AM ET on Monday Jun 10, 2024 by Dow Jones
8:04AM ET on Monday Jun 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Shattuck Labs Inc | 218.3M | -2.2x | --- |
Q32 Bio Inc | 217.2M | -0.6x | --- |
Inhibrx Biosciences Inc | 210.9M | -2.7x | --- |
Inovio Pharmaceuticals Inc | 221.8M | -1.5x | --- |
Aldeyra Therapeutics Inc | 215.7M | -6.7x | --- |
Monte Rosa Therapeutics Inc | 215.4M | -1.4x | --- |
Company Information
Shattuck Labs, Inc. is a clinical-stage biotechnology company. The Company is engaged in the development of bi-functional fusion proteins as a new class of biologic medicine for the treatment of patients with cancer and autoimmune disease. Its lead product candidate, SL-172154, is designed to simultaneously inhibit the CD47/SIRPa macrophage checkpoint interaction and activate the CD40 costimulatory receptor to induce an antitumor immune response. It is conducting a Phase IA/B clinical trial in patients with acute myeloid leukemia (AML) and HR-MDS. It has completed the Phase IA dose-escalation portion of this clinical trial and are enrolling patients in the Phase IB expansion cohorts evaluating SL-172154 in combination with azacitidine in frontline HR-MDS or frontline TP53 mutant (TP53m) AML. It has developed the ARC platform to address the need for a single therapeutic that consolidates multiple immune functions.
Contact Information
- Headquarters
- 500 W. 5Th Street, Suite 100AUSTIN, TX, United States 78701
- Phone
- 512-900-4690
- Fax
- ---
Executives
- Independent Chairman of the Board
- George Golumbeski
- Chief Executive Officer, Co-Founder, Director
- Taylor Schreiber
- Chief Financial Officer
- Andrew Neill
- General Counsel, Corporate Secretary and Chief Ethics and Compliance Officer
- Stephen Stout
- Chief Business Officer
- Casi Deyoung
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $218.3M |
|---|---|
Revenue (TTM) | $2.7M |
Shares Outstanding | 47.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.76 |
EPS | $-1.93 |
Book Value | $3.06 |
P/E Ratio | -2.2x |
Price/Sales (TTM) | 80.4 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -3,327.44% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
